Status:

ACTIVE_NOT_RECRUITING

The Impact of Targeted Temperature Management Duration on Thrombin Function in Cardiac Arrest Patients

Lead Sponsor:

Tang Ziren

Conditions:

Targeted Temperature Management

Cardiac Arrest

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

This study will be a single-center, prospective, randomized controlled trial with an estimated sample size of 64 patients. Eligible patients will be randomly assigned in a 1:1 ratio to receive TTM for...

Eligibility Criteria

Inclusion

  • age between 18 and 80 years;
  • Glasgow Coma Scale score of less than 8 upon admission;
  • patients resuscitated after out-of-hospital cardiac arrest; and (4) patient or their legal representative has signed the informed consent form.

Exclusion

  • cardiac arrest caused by irreversible factors such as trauma or poisoning;
  • cardiac arrest due to terminal conditions like advanced cancer;
  • uncorrected persistent cardiogenic shock, defined as a systolic blood pressure below 90 mmHg despite treatment with fluid resuscitation, vasopressors, and inotropic agents;
  • pre-existing cerebrovascular disease or CT-confirmed intracerebral hemorrhage upon admission;
  • pre-arrest Cerebral Performance Category (CPC) score between 3 and 5;
  • bradycardia or sick sinus syndrome following the return of spontaneous circulation;
  • pre-existing coagulation disorders or severe bleeding tendencies;
  • pregnant or breastfeeding women, or women of childbearing age with elevated serum hCG levels;
  • presence of treatment limitations (such as refusal by the patient or legal representative to undergo advanced life support, including mechanical ventilation, chest compressions, or targeted temperature management);
  • determination by the principal investigator that the patient is unsuitable for the trial.

Key Trial Info

Start Date :

December 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

64 Patients enrolled

Trial Details

Trial ID

NCT06543849

Start Date

December 1 2024

End Date

December 31 2025

Last Update

April 11 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Beijing chao-yang Hospital, Capital Medical University

Beijing, Beijing Municipality, China

The Impact of Targeted Temperature Management Duration on Thrombin Function in Cardiac Arrest Patients | DecenTrialz